Bilthoven Biologicals

Bilthoven Biologicals is a well-established, mission-driven vaccine manufacturer with a century-long history, now operating as a strategic European arm of the Serum Institute of India. The company leverages its manufacturing expertise and global partnerships to produce and develop vaccines aimed at increasing global accessibility and pandemic preparedness. Its recent milestones include opening new pandemic preparedness facilities and gaining European marketing authorization for a novel tuberculosis diagnostic, positioning it as a key player in global public health.

Large-scale GMP manufacturing of biologicals and vaccines, including a dedicated pandemic preparedness production facility.

Competes with other large vaccine manufacturers like GSK, Sanofi, and Pfizer in some markets, but its primary niche is the high-volume, low-cost segment dominated by its parent company, Serum Institute of India. Also faces competition from emerging market manufacturers and CDMOs for partnership contracts.